The American Hospital Association (AHA) is pushing back forcefully against the Health Resources and Services Administration’s (HRSA) new 340B rebate [...] …
Year: 2025
SPONSORED CONTENT
Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need to protect themselves from the problem of duplicate discounts. Federal law affords such protection for drugs dispensed or administered to Medicaid
…
A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...] …
Rural health advocates are sounding alarms over the surge in large urban hospitals reclassifying as rural under Medicare, warning this [...] …
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...] …
Drugmaker AstraZeneca recently filed a pair of federal lawsuits seeking to block 340B contract pharmacy access laws in North and [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The 340B provider community was rocked two years ago by the announcement of an alliance between the nation’s largest and [...] …

SPONSORED CONTENT

TIP: Maximize 340B savings by manually pulling in rejected and qualified claims.
Manually pulling in rejected and
The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...] …